Raphael Parmigiani works at IdenGene. The Oncoclinic Group practices personalized medicine for the individualization of the treatment of its patients. It understands that an assertive cancer treatment most often depends on a molecular evaluation of the tumor or even on the identification of germline mutations present in the patients. IdenGene laboratory performs molecular and genomic biology tests, such as identification of patients with mutations allows preventive risk reduction measures and early diagnosis. Other tests offered by the laboratory include examinations performed on the tumor sample itself, by which it is possible to study the molecular changes present in their DNA and thus identify with which treatments the patients have the greatest potential for benefit.